Plasma thrombin-activatable fibrinolysis inhibitor as an indicator of inflammation and disease severity in acute pancreatitis

Sayilir, Abdurrahim; Beyazit, Yavuz; YEŞİL, YUSUF; Albayrak, Murat; Ekiz, Fuat; Celik, Tugrul; Suvak, Burak; Torun, Serkan; Ibis, Mehmet

doi:10.1016/j.clinre.2011.12.006

Plasma thrombin-activatable fibrinolysis inhibitor as an indicator of inflammation and disease severity in acute pancreatitis

Atıf İçin Kopyala

Sayilir A., Beyazit Y., YEŞİL Y., Albayrak M., Ekiz F., Celik T., ...Daha Fazla

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, cilt.36, sa.5, ss.498-504, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 5
Basım Tarihi: 2012
Doi Numarası: 10.1016/j.clinre.2011.12.006
Dergi Adı: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.498-504
Hacettepe Üniversitesi Adresli: Evet

Özet

Aim: In addition to suppressing fibrinolysis, thrombin activatable fibrinolysis inhibitor (TAFI) was suggested to be involved in inflammation. To date, no study has been published that reports the role of TAFI in acute pancreatitis (AP). Therefore, the objective of the present study was to investigate the role of plasma TAFI as an indicator of inflammation in AP, and its association with disease severity.